Medicare Claims Processing Billing Requirements for Positron Emission Tomography (PET) Scans for Dementia and Neurodegenerative Diseases
Guidance for payers regarding billing and claims processing requirements for PET Scans for beneficiaries with either a differential diagnosis of fronto-temporal dementia (FTD) and Alzheimer’s disease (AD) OR; its use in a CMS-approved practical clinical trial focused on the utility of FDG-PET in the diagnosis or treatment of dementing neurodegenerative diseases.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: October 01, 2004
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.